特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
952603

新型コロナウイルス感染症 (COVID-19) 治療薬送達デバイスの世界市場 (2022-2027年):プレフィルドシリンジ・パッチ

COVID-19 Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product (Prefilled Syringe, Patches), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 108 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.81円
新型コロナウイルス感染症 (COVID-19) 治療薬送達デバイスの世界市場 (2022-2027年):プレフィルドシリンジ・パッチ
出版日: 2020年07月03日
発行: Grand View Research, Inc.
ページ情報: 英文 108 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の新型コロナウイルス感染症 (COVID-19) 治療薬送達デバイスの市場は予測期間中8.1%のCAGRで推移し、2027年には21億5000万米ドルの規模に成長すると予測されています。COVID-19ワクチン投与に向けた様々な経鼻薬剤送達技術が臨床および前臨床開発中であり、同市場は予測期間中に大きな成長を示すと予測されています。

当レポートでは、世界の新型コロナウイルス感染症 (COVID-19) 治療薬送達デバイスの市場を調査し、市場および製品の概要、バリューチェーン、市場成長への各種影響因子の分析、市場規模の推移・予測、製品・投与経路・流通経路・地域/主要国など各種区分別の内訳、競合環境、主要企業プロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 産業の展望
  • 普及率・成長率の見通し
  • 産業バリューチェーンの分析
  • 市場力学
  • 市場分析ツール

第4章 市場予測・動向分析:製品別

  • 定義・範囲
  • 市場シェア実績・予測
  • ダッシュボード
  • 市場予測
    • プレフィルドシリンジ
    • 無針注射器
    • 吸入器
    • パッチ

第5章 市場予測・動向分析:投与経路別

  • 定義・範囲
  • 市場シェア実績・予測
  • ダッシュボード
  • 市場予測
    • 非経口
    • 経鼻
    • 経皮

第6章 市場予測・動向分析:流通経路別

  • 定義・範囲
  • 市場シェア実績・予測
  • ダッシュボード
  • 市場予測
    • 院内薬局
    • 小売薬局
    • オンライン薬局

第7章 市場予測・動向分析:地域・主要国別

  • 国別シェア実績・予測
  • ダッシュボード
  • 市場概要
  • 地域シェア・主要企業
  • SWOT分析
  • 市場規模・予測
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第8章 競合情勢

  • 主要企業・近年の動向・産業への影響
  • 主要企業・競合上の分類
  • ベンダー環境
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
  • Table 3 North America COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 4 North America COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 5 North America COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 6 U.S. COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 7 U.S. COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 8 U.S. COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 9 Canada COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 10 Canada COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 11 Canada COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 12 Europe COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
  • Table 13 Europe COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 14 Europe COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 15 Europe COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 16 U.K. COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 17 U.K. COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 18 U.K. COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 19 Germany COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 20 Germany COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 21 Germany COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 22 Italy COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 23 Italy COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 24 Italy COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 25 Spain COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 26 Spain COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 27 Spain COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 28 France COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 29 France COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 30 France COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 31 Asia Pacific COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
  • Table 32 Asia Pacific COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 33 Asia Pacific COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 34 Asia Pacific COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 35 Japan COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 36 Japan COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 37 Japan COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 38 China COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 39 China COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 40 China COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 41 India COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 42 India COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 43 India COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 44 South Korea COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 45 South Korea COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 46 South Korea COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 47 Australia COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 48 Australia COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 49 Australia COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 50 Latin America COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
  • Table 51 Latin America COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 52 Latin America COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 53 Latin America COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 54 Brazil COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 55 Brazil COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 56 Brazil COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 57 Mexico COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 58 Mexico COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 59 Mexico COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 60 Argentina COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 61 Argentina COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 62 Argentina COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 63 Colombia COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 64 Colombia COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 65 Colombia COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 66 Middle East and Africa COVID-19 drug delivery devices market, by country, 2020 - 2027 (USD Million)
  • Table 67 Middle East and Africa COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 68 Middle East and Africa COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 69 Middle East and Africa COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 70 South Africa COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 71 South Africa COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 72 South Africa COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 73 Saudi Arabia COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 74 Saudi Arabia COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 75 Saudi Arabia COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)
  • Table 76 UAE COVID-19 drug delivery devices market, by product, 2020 - 2027 (USD Million)
  • Table 77 UAE COVID-19 drug delivery devices market, by route of administration, 2020 - 2027 (USD Million)
  • Table 78 UAE COVID-19 drug delivery devices market, by distribution channel, 2020 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 COVID-19 drug delivery device market, 2018
  • Fig. 14 COVID-19 drug delivery device market segmentation
  • Fig. 15 COVID-19 drug delivery device market trends
  • Fig. 16 COVID-19 drug delivery device market: Market driver impact
  • Fig. 17 COVID-19 drug delivery device market: Market restraint impact
  • Fig. 18 Penetration & Growth Prospect Mapping
  • Fig. 19 COVID-19 drug delivery device market - PESTLE Analysis
  • Fig. 20 Industry Analysis - Porter's
  • Fig. 21 COVID-19 drug delivery device market competitive landscape: Market position analysis (Based on product, regional presence)
  • Fig. 22 COVID-19 drug delivery device market: Product outlook key takeaways
  • Fig. 23 COVID-19 drug delivery device market: Product movement analysis
  • Fig. 24 COVID-19 drug delivery device market: Route of administration outlook key takeaways
  • Fig. 25 COVID-19 drug delivery device market: Route of administration movement analysis
  • Fig. 26 COVID-19 drug delivery device market: Distribution channel outlook key takeaways
  • Fig. 27 COVID-19 drug delivery device market: Distribution channel movement analysis
  • Fig. 28 Regional marketplace, 2016 - 2027 (USD Million)
  • Fig. 29 North America COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 30 U.S. COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 31 Canada COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 32 Europe COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 33 U.K. COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 34 Germany COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 35 France COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 36 Italy COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 37 Spain COVID-19 drug delivery device market, 2016 - 2027 (USD Million)
  • Fig. 38 Asia Pacific COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 39 Japan COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 40 China COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 41 India COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 42 South Korea COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 43 Australia COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 44 Latin America COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 45 Brazil COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 46 Mexico COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 47 Argentina COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 48 Colombia COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 49 Middle East and Africa COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 50 South Africa COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 51 Saudi Arabia COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
  • Fig. 52 UAE COVID-19 drug delivery devices market, 2016 - 2027 (USD Million)
目次
Product Code: GVR-4-68038-785-8

Market Growth & Trends

The global COVID-19 drug delivery devices market size is expected to reach USD 2.15 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2022 to 2027.

The market is expected to gain significant traction over the forecast period as various nasal drug delivery technologies for administrating COVID-19 vaccines are under clinical and pre-clinical development. For instance, in April 2020, Verndari, Inc. initiated the preclinical trials for coronavirus vaccine using its patented microneedle array dermal patch- VaxiPatch.

The nasal, dermal, and needle-free are the alternatives to the traditional syringe vaccine platforms. These devices potentially reduce or eliminate needlestick injuries and reduce the associated treatment costs. According to the research article published in PLUS ONE Journal, November 2019, needlestick injury (NSI) is among a major burden in medical settings, leading to the transmission of infectious diseases, such as hepatitis and HIV.

According to the article published in StatPearls publishing, December 2019, around 2-4% healthcare workers develop hepatitis C after suffering from needlestick injuries. The CDC further stated that needlestick injuries cost an estimated USD 3,042 per victim annually in U.S.

Report Highlights:

  • North America is anticipated to capture the largest share in 2021 owing to growing investment by government organizations for vaccine development, surge in COVID-19 cases, and intensive R&D conducted by the key players
  • By product, the prefilled syringe segment is expected to dominate the market in 2021 as these cost-effective delivery devices will be manufactured in bulk quantities for vaccine administration and will be the first among the approved products
  • By route of administration, the parenteral segment is expected to dominate the market in 2021 as the injection devices are affordable and are among the easily available devices
  • By distribution channel, the hospital pharmacies segment is expected to account for the largest market share in 2021 as these drug delivery devices require medical assistance for vaccine administration
  • Market players are adopting several strategies such as significant investment in research and development and product innovation via collaborations with technology providers and universities to gain a significant share in the global market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. By Product
    • 1.1.2. By Route of Administration
    • 1.1.3. By Distribution Channel
    • 1.1.4. Country scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Route of Administration outlook
    • 2.2.3. Distribution Channel outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. COVID-19 Drug Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Growth in government funding to support vaccine production
      • 3.4.1.2. Development of novel non-invasive drug delivery technologies
      • 3.4.1.3. Increasing collaborations among universities and market players
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High research and development costs
      • 3.4.2.2. Limited vaccine production facilities and lack of data supporting efficacy
  • 3.5. COVID-19 Drug Delivery Devices Market Analysis Tools
    • 3.5.1. Industry analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major deals & strategic alliances analysis
    • 3.5.4. Market entry strategies

Chapter 4. COVID-19 Drug Delivery Devices Market: By Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Prefilled syringe
    • 4.1.2. Needle-free injectors
    • 4.1.3. Inhalers
    • 4.1.4. Patches
  • 4.2. Product Market Share, 2020 & 2027
  • 4.3. Segment Dashboard
  • 4.4. Global COVID-19 Drug Delivery Devices Market, by Product Outlook
    • 4.4.1. Prefilled syringe
      • 4.4.1.1. Prefilled syringe market estimates and forecast, 2016 - 2027 (USD Million)
    • 4.4.2. Needle-free injectors
      • 4.4.2.1. Needle-free injectors market estimates and forecast, 2016 - 2027 (USD Million)
    • 4.4.3. Inhalers
      • 4.4.3.1. Inhalers market estimates and forecast, 2016 - 2027 (USD Million)
    • 4.4.4. Patches
      • 4.4.4.1. Patches market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 5. COVID-19 Drug Delivery Devices Market: By Route of Administration Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Parenteral
    • 5.1.2. Nasal
    • 5.1.3. Dermal
  • 5.2. By Route of Administration Market Share, 2020 & 2027
  • 5.3. Segment Dashboard
  • 5.4. Global COVID-19 Drug Delivery Devices Market, by Route of Administration Outlook
    • 5.4.1. Parenteral
      • 5.4.1.1. Parenteral market estimates and forecast, 2016 - 2027 (USD Million)
    • 5.4.2. Nasal
      • 5.4.2.1. Nasal market estimates and forecast, 2016 - 2027 (USD Million)
    • 5.4.3. Dermal
      • 5.4.3.1. Dermal market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 6. COVID-19 Drug Delivery Devices Market: By Distribution Channel Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospital pharmacies
    • 6.1.2. Retail pharmacies
    • 6.1.3. Online pharmacies
  • 6.2. By Distribution Channel Market Share, 2020 & 2027
  • 6.3. Segment Dashboard
  • 6.4. Global COVID-19 Drug Delivery Devices Market, by Distribution Channel Outlook
    • 6.4.1. Hospital pharmacies
      • 6.4.1.1. Hospital pharmacies market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.4.2. Retail pharmacies
      • 6.4.2.1. Retail pharmacies market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.4.3. Online pharmacies
      • 6.4.3.1. Online pharmacies market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 7. COVID-19 Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Country Market Share Analysis, 2020 & 2027
  • 7.2. County Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2020
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 to 2027:
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.7.2. U.S.
      • 7.7.2.1. U.S. market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.7.3. Canada
      • 7.7.3.1. Canada market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.8. Europe
    • 7.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.2. U.K.
      • 7.8.2.1. U.K. market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.3. Germany
      • 7.8.3.1. Germany market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.4. France
      • 7.8.4.1. France market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.5. Italy
      • 7.8.5.1. Italy market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.8.6. Spain
      • 7.8.6.1. Spain market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.2. Japan
      • 7.9.2.1. Japan market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.3. China
      • 7.9.3.1. China market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.4. India
      • 7.9.4.1. India market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.5. South Korea
      • 7.9.5.1. South Korea market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.9.6. Australia
      • 7.9.6.1. Australia market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.10. Latin America
    • 7.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.10.2. Brazil
      • 7.10.2.1. Brazil market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.10.3. Mexico
      • 7.10.3.1. Mexico market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.10.4. Argentina
      • 7.10.4.1. Argentina market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.10.5. Colombia
      • 7.10.5.1. Colombia market estimates and forecast, 2016 - 2027 (USD Million)
  • 7.11. Middle East & Africa
    • 7.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.11.2. South Africa
      • 7.11.2.1. South Africa market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.11.3. Saudi Arabia
      • 7.11.3.1. Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
    • 7.11.4. UAE
      • 7.11.4.1. UAE market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2020
    • 8.3.4. AstraZeneca
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Johnson & Johnson
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Serum Institute of India
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. GlaxoSmithKline plc
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Moderna
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Bharat Biotech
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. PharmaJet
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Pfizer
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Novavax, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.